Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1116 of 6351
-
Mapping cancer DNA to match patients with targeted drugs
Knowledge-focused Recruiting nowThe genomic heterogeneity of cancers implies that to effectively use targeted therapies the investigators will need to assess each individual cancer and match it to a biologically relevant targeted therapy. The investigators will use full genome sequencing to try to identify canc…
Sponsor: British Columbia Cancer Agency • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Blood test could guide chemo for throat cancer patients
Disease control OngoingThere are two study questions we are asking in this randomized phase II/III trial based on a blood biomarker, Epstein Barr virus (EBV) deoxyribonucleic acid (DNA) for locoregionally advanced non-metastatic nasopharyngeal cancer. All patients will first undergo standard concurrent…
Phase 2/3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could an immune-boosting pill make melanoma treatments work better?
Disease control CompletedTo evaluate the preliminary efficacy of the established dose of indoximod in combination with immune checkpoint inhibition as measured by the best overall response rate (ORR) (complete response (CR) + partial response (PR))across both standard of care agents administered sequenti…
Phase 1/2 • Sponsor: NewLink Genetics Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Plastic meniscus implant put to the test against standard care for knee pain
Disease control CompletedThe NUsurface® Meniscus Implant Randomized Study is a multi-center, prospective randomized, interventional clinical trial to test the hypothesis that the NUsurface implant is superior to the non-surgical standard of care in treating the target population.The rationale for perform…
Sponsor: Active Implants • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Does a Mother's weight change the chemistry of her breast milk?
Knowledge-focused OngoingToday the majority of pregnant women in the United States are either overweight or obese at conception with their offspring having greater adiposity at birth, a 2-fold greater risk of later obesity, and neonatal insulin resistance. It was long thought that breast milk composition…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
New combo aims to wipe out leukemia cells in younger patients
Disease control OngoingThis research study is evaluating a new drug called IPI-145 in combination with the standard drugs fludarabine, cyclophosphamide, and rituximab (FCR), as a possible treatment for chronic lymphocytic leukemia (CLL).
Phase 1/2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a vaccine stop colon cancer before it starts?
Vaccine OngoingThis randomized phase II clinical trial studies how well MUC1 peptide-poly-ICLC adjuvant vaccine works in treating patients with newly diagnosed advanced colon polyps (adenomatous polyps). Adenomatous polyps are growths in the colon that may develop into colorectal cancer over ti…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Vaccine
Last updated Aug 02, 2026 00:00 UTC
-
Supercharged immune cells take on tough lymphoma after transplant
Disease control OngoingThis phase I trial studies the highest possible dose of memory enriched T cells that can be given following standard stem cell transplant before unmanageable side effects are seen in patients with B-cell non-Hodgkin lymphoma that has returned after previous treatment. A T cell is…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Can a pill replace EPO shots for anemia in kidney disease?
Disease control Stopped earlyThe study will evaluate the ability of GSK1278863 to increase the hemoglobin (Hgb) concentration, or maintain it within the target range, and the safety and efficacy of GSK1278863 over 16 weeks of treatment, in hemodialysis-dependent subjects with anemia associated with chronic k…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New asthma drug aims to improve breathing without daily pills
Disease control CompletedThis Phase III, randomized, double-blind, placebo-controlled, multicenter study will assess the efficacy and safety of lebrikizumab in adult patients with mild to moderate asthma treated with short-acting beta-agonist (SABA) therapy alone. Patients will be randomized in a 1:1:1 r…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Light therapy shows promise against tough lung cancer
Disease control OngoingA randomized Phase II trial to test whether the addition of intraoperative Photofrin-mediated photodynamic therapy to radical pleurectomy and post-operative chemo.improves OS in the treatment of patients with epithelioid MPM. Subjects assigned to the PDT arm will be given the pho…
Phase 2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can a Low-Dose anesthetic cut opioid use after hysterectomy?
Symptom relief CancelledThis study investigates the effect of low dose S+ketamine compared to placebo on cumulative morphine consumption at 24 hours in women undergoing open abdominal hysterectomy with remifentanil-propofol target controlled infusion. It compares the adverse effect profile in patients r…
Sponsor: KK Women's and Children's Hospital • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
New drug combo shows promise for untreated leukemia patients
Disease control CompletedThis research study is evaluating a combination of drugs called Ofatumumab and Idelalisib as a possible treatment for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Leukemia (SLL). The main purpose of this study is to examine the combination of the two drugs, Ofatumuma…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Custom stents aim to cut deaths from tricky aortic aneurysms
Disease control Recruiting nowThis is a single-center study to evaluate the safety and effectiveness of three investigational devices, the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and the Surgeon-Modified Endografts in the treatment of Juxtarenal, Suprarenal, Thoracoabdominal, and…
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Tailored hormone dosing may spare preemies from blood transfusions
Disease control CompletedNeonatal anemia is the most commonly encountered hematologic problem among all neonates cared for in the neonatal intensive care unit (NICU). This project seeks to better understand the pathophysiology and treatment of this challenging and important condition, especially as it af…
Phase 2 • Sponsor: University of Iowa • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
A chill buzz vs. a needle: can a device replace a drug for Kids' pain?
Symptom relief Stopped earlyPropofol is a drug commonly used for induction of general anesthesia in children as well as adults; however, propofol can cause pain on injection, possibly more frequently in children. One common method of preventing propofol injection pain is the injection of lidocaine just prio…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
New combo shows promise for Tough-to-Treat blood cancer
Disease control CompletedThis trial will evaluate the efficacy and safety of combination of pomalidomide (POM) and low-dose dexamethasone (LD-Dex) (Cohort A) or the combination of pomalidomide (POM) , daratumumab (DARA) and low-dose dexamethasone (LD-Dex) (Cohort B) in subjects with relapsed or refractor…
Phase 2 • Sponsor: Celgene • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New chemo cocktail targets tough leukemias
Disease control Recruiting nowThis phase II trial studies how well cladribine, idarubicin, cytarabine, and venetoclax work in patients with acute myeloid leukemia, high-risk myelodysplastic syndrome, or blastic phase chronic myeloid leukemia. Drugs used in chemotherapy, such as cladribine, idarubicin, cytarab…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Gene-Targeted cancer therapy put to the test in major trial
Disease control OngoingThis randomized clinical trial studies how molecular profiling and targeted therapy work in treating patients with cancer that has spread to other places in the body compared to standard treatment. Information about genetic differences in a patient's tumor can be used to choose t…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Second radiation course shows promise for returning brain tumors in kids
Disease control OngoingThe primary purpose of this study is to investigate whether surgery and re-irradiation will help treat ependymoma that has come back after initial treatment. The combined doses of the first and second courses of radiation are higher than what is usual standard of care. The invest…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC